JHP Pharmaceuticals buys NitroMed's BiDil for $26.3mm; ends
JHP Pharmaceuticals has bought all of NitroMed's BiDil (isosorbide dinitrate/hydralazine) assets for $24.5mm in cash plus $1.8mm for inventory and will assume certain liabilities.
- Includes Equity
- Marketing (Licensing)
- Product Purchase
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.